AGO2 and non-small cell lung carcinoma: The enhancement was significant in the AGO2-silenced cells (via AGO2 siRNA or miR138 mimic) compared with that of the control small RNA transfection group (Fig. 2h), suggesting an AGO2-specific stability effect in the tested human NSCLC cells.